Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in the psychotherapy of addictive disorders

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Rigorous research has recently identified a range of behavioral therapies that have been shown to be effective across the most prevalent types of substance dependence. This review summarizes the roles of behavioral therapies as contrasted with those of pharmacotherapies for substance use disorders and then provides an overview of the major classes of behavioral therapies (clinical management, coping skills approaches, motivational interviewing, and family and interpersonal approaches), highlighting their effectiveness across cocaine, opioid, alcohol, and cannabis use disorders. Lastly, important areas of current research emphasis including combined treatments, strategies for effectively transporting empirically validated treatments into clinical practice, and increasing the efficiency of treatment are described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Miller WR, Wilbourne PL: Mesa Grande: A methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 2002, 97:265–277. This is an important evaluation of the quality of clinical trials on substance abuse treatment.

    Article  PubMed  Google Scholar 

  2. Kalivas PW: Recent understanding in the mechanisms of addiction. Curr Psychiatry Rep 2004, 6:347–351.

    PubMed  Google Scholar 

  3. Goldstein R, Volkow ND: Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002, 159:1642–1652.

    Article  PubMed  Google Scholar 

  4. O’Brien CP: A range of research-based pharmacotherapies for addiction. Science 1997, 278:66–70.

    Article  PubMed  CAS  Google Scholar 

  5. Dackis CA: Recent advances in the pharmacotherapy of cocaine dependence. Curr Psychiatry Rep 2004, 6:323–331.

    PubMed  Google Scholar 

  6. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM: Conceptual and methodologic issues in comparative studies of psychotherapy and pharmacotherapy, I: Active ingredients and mechanisms of change. Am J Psychiatry 1988, 145:909–917.

    PubMed  CAS  Google Scholar 

  7. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM: Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, II: Nature and timing of treatment effects. Am J Psychiatry 1988, 145:1070–1076.

    PubMed  CAS  Google Scholar 

  8. O’Malley SS, Jaffe AJ, Chang G, et al.: Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry 1992, 49:881–887.

    PubMed  CAS  Google Scholar 

  9. Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992, 49:876–880.

    PubMed  CAS  Google Scholar 

  10. Carroll KM, Fenton LR, Ball SA, et al.: Efficacy of disulfiram and cognitive-behavioral therapy in cocaine-dependent outpatients: A randomized placebo controlled trial. Arch Gen Psychiatry 2004, 64:264–272.

    Article  Google Scholar 

  11. Rounsaville BJ, Carroll KM: Individual psychotherapy for drug abusers. In Comprehensive Textbook of Substance Abuse, Third Edition. Edited by Lowinsohn JH, Ruiz P, Miller RB. New York: Williams & Wilkins; 1997:430–439.

    Google Scholar 

  12. Miller WR, Rollnick S: Motivational Interviewing: Preparing People for Change, Second Edition. New York: Guilford Press; 2002.

    Google Scholar 

  13. Carroll KM: A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, Maryland: NIDA; 1998.

    Google Scholar 

  14. Marlatt GA, Donovan D: Relapse Prevention: Maintenance Strategies in the Treatment of Addictions, Second Edition. New York: The Guilford Press; 2005.

    Google Scholar 

  15. Budney AJ, Higgins ST: A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. Rockville, MD: NIDA; 1998.

    Google Scholar 

  16. Higgins ST, Budney AJ, Bickel WK, et al.: Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994, 51:568–576.

    PubMed  CAS  Google Scholar 

  17. Fals-Stewart W, O’Farrell TJ: Behavioral family counseling and naltrexone for male opioid-dependent patients. J Consult Clin Psychol 2003, 71:432–442.

    Article  PubMed  Google Scholar 

  18. Henggeler SW, Borduin CM: Family Therapy and Beyond: A Multisystemic Approach to Treating the Behavior Problems of Children and Adolescents. Pacific Grove, CA: Brooks/Cole; 1990.

    Google Scholar 

  19. Carroll KM: Manual guided psychosocial treatment: A new virtual requirement for pharmacotherapy trials? Arch Gen Psychiatry 1997, 54:923–928.

    PubMed  CAS  Google Scholar 

  20. Haynes RB, Taylor DW, Sackett DL: Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979.

    Google Scholar 

  21. Roter DL, Hall JA, Merisca R, et al.: Effectiveness of interventions to improve patient compliance: A meta-analysis. Med Care 1998, 36:1138–1161.

    Article  PubMed  CAS  Google Scholar 

  22. O’Farrell TJ, Litten RZ: Techniques to enhance compliance with disulfiram. Alcohol Clin Exp Res 1992, 16:1035–1041.

    Article  Google Scholar 

  23. Meichenbaum DH, Turk DC, eds: Facilitating Treatment Adherence. New York: Plenum Press; 1987.

    Google Scholar 

  24. Carroll KM, Onken LS: Behavioral therapies for drug abuse: A thirty year progress report. Am J Psychiatry, In press.

  25. Higgins ST, Silverman K: Motivating Behavior Change Among Illicit-Drug Abusers. Washington, DC: American Psychological Association; 1999.

    Google Scholar 

  26. Higgins ST, Delany DD, Budney AJ, et al.: A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry 1991, 148:1218–1224.

    PubMed  CAS  Google Scholar 

  27. Higgins ST, Budney AJ, Bickel WK, Hughes JR: Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993, 150:763–769.

    PubMed  CAS  Google Scholar 

  28. Higgins ST, Wong CJ, Badger GJ, et al.: Contingent reinforcement increases cocaine abstinence during outpatient treatment and one year follow-up. J Consult Clin Psychol 2000, 68:64–72.

    Article  PubMed  CAS  Google Scholar 

  29. Higgins ST, Alessi SM, Dantona RL: Voucher-based incentives: A substance abuse treatment innovation. Addict Behav 2002, 27:887–910.

    Article  PubMed  Google Scholar 

  30. Silverman K, Higgins ST, Brooner RK, et al.: Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996, 53:409–415.

    PubMed  CAS  Google Scholar 

  31. Silverman K, Wong CJ, Umbricht-Schneiter A, et al.: Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J Consult Clin Psychol 1998, 66:811–824.

    Article  PubMed  CAS  Google Scholar 

  32. Milby JB, Schumacher JE, Raczynski JM, et al.: Sufficient conditions for effective treatment of substance abusing homeless persons. Drug Alcohol Depend 1996, 43:39–47.

    Article  PubMed  CAS  Google Scholar 

  33. Kirby KC, Marlowe DB, Festinger DS, et al.: Schedule of voucher delivery influences initiation of cocaine abstinence. J Consult Clin Psychol 1998, 66:761–767.

    Article  PubMed  CAS  Google Scholar 

  34. Silverman K, Svikis DS, Wong CJ, et al.: A reinforcement-based therapeutic workplace for the treatment of drug abuse: Three year abstinence outcomes. Exp Clin Psychopharmacol 2002, 10:228–240.

    Article  PubMed  Google Scholar 

  35. Jones HE, Haug NA, Silverman K, et al.: The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone maintained pregnant women. Drug Alcohol Depend 2001, 61:297–306.

    Article  PubMed  CAS  Google Scholar 

  36. Budney AJ, Higgins ST, Radonovich KJ, Novy PL: Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000, 68:1051–1061.

    Article  PubMed  CAS  Google Scholar 

  37. Carroll KM, Ball SA, Martino S: Cognitive, behavioral, and motivational therapies. In The American Psychiatric Publishing Textbook of Substance Abuse Treatment, Third Edition. Edited by Galanter M, Kleber HD. Washington, DC: American Psychiatric Publishing; 2004:365–376.

    Google Scholar 

  38. Iguchi MY, Lamb RJ, Belding, et al.: Contingent reinforcement of group participation versus abstinence in a methadone maintenance program. Exp Clin Psychopharmacol 1996, 4:1–7.

    Google Scholar 

  39. Petry NM, Alessi SM, Carroll KM, et al.: Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities. Under review. 2005.

  40. Carroll KM, Ball SA, Nich C, et al.: Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: Efficacy of contingency management and significant other involvement. Arch Gen Psychiatry 2001, 58:755–761.

    Article  PubMed  CAS  Google Scholar 

  41. Carroll KM, Sinha R, Nich C, et al.: Contingency management to enhance naltrexone treatment of opioid dependence: A randomized clinical trial of reinforcement magnitude. Exp Clin Psychopharmacol 2002, 10:54–63.

    Article  PubMed  CAS  Google Scholar 

  42. Preston KL, Silverman K, Umbricht A, et al.: Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend 1999, 54:127–135.

    Article  PubMed  CAS  Google Scholar 

  43. Rigsby MO, Rosen MI, Beauvais J, Cramer JA, Rainey PM, O’Malley SS, Dieckhaus KD, Rounsaville BJ: Cue dose training with monetary reinforcement: Pilot study of an antiretroviral adherence intervention. J Gen Intern Med 2000, 15:841–847.

    Article  PubMed  CAS  Google Scholar 

  44. Petry NM, Martin B, Cooney JL, Kranzler HR: Give them prizes and they will come: Contingency management treatment of alcohol dependence. J Consult Clin Psychol 2000, 68:250–257.

    Article  PubMed  CAS  Google Scholar 

  45. Petry NM, Martin B: Low-cost contingency management for treating cocaine- and opioid abusing methadone patients. J Consult Clin Psychol 2002, 70:398–405. This study showed the effectiveness of low-cost incentives.

    Article  PubMed  Google Scholar 

  46. Petry NM, Tedford J, Austin M, et al.: Prize reinforcement contingency management for treating cocaine abusers: You get what you pay for: how low can we go, and with whom? Addiction 2004, 99:349–360.

    Article  PubMed  Google Scholar 

  47. Petry NM, Martin B, Simcic F: Prize reinforcement contingency management for cocaine dependence: Integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005, 73:354–359.

    Article  PubMed  Google Scholar 

  48. Carroll KM: Behavioral and cognitive behavioral treatments. In Addictions: A Comprehensive Guidebook. Edited by McCrady BS, Epstein EE. New York: Oxford University Press; 1999:250–267.

    Google Scholar 

  49. Carroll KM: Relapse prevention as a psychosocial treatment approach: A review of controlled clinical trials. Exp Clin Psychopharmacol 1996, 4:46–54.

    Article  Google Scholar 

  50. Irvin JE, Bowers CA, Dunn ME, Wong MC: Efficacy of relapse prevention: A meta-analytic review. J Consult Clin Psychol 1999, 67:563–570. This is an important meta-analysis of coginitive-behavioral approaches.

    Article  PubMed  CAS  Google Scholar 

  51. Morgenstern J, Longabaugh R: Cognitive-behavioral treatment for alcohol dependence: A review of the evidence for its hypothesized mechanisms of action. Addiction 2000, 95:1475–1490.

    Article  PubMed  CAS  Google Scholar 

  52. MTP Research Group: Brief treatments for cannabis dependence: Findings from a randomized multisite trial. J Consult Clin Psychol 2004, 72:455–466. This study compared the efficacy of motivational enhancement therapy, multicomponent therapy, and a delayed-treatment control.

    Article  Google Scholar 

  53. Stephens R, Roffman RA, Curtin L: Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol 2000, 68:898–908.

    Article  PubMed  CAS  Google Scholar 

  54. Carroll KM, Rounsaville BJ, Gordon LT, et al.: Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994, 51:177–197.

    PubMed  CAS  Google Scholar 

  55. Carroll KM, Nich C, Ball SA, et al.: Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998, 93:713–728.

    Article  PubMed  CAS  Google Scholar 

  56. McKay JR, Alterman AI, Cacciola JS, et al.: Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence. J Consult Clin Psychol 1997, 65:778–788.

    Article  PubMed  CAS  Google Scholar 

  57. Rohsenow DJ, Monti PM, Martin RA, et al.: Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol 2000, 68:515–520.

    Article  PubMed  CAS  Google Scholar 

  58. Fiore MC, Smith SS, Jorenberg DE, Baker TB: The effectiveness of the nicotine patch for smoking cessation: A meta-analysis. JAMA 1994, 271:1940–1947.

    Article  PubMed  CAS  Google Scholar 

  59. Hall SM, Reus VI, Munoz RF, et al.: Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998, 55:683–690.

    Article  PubMed  CAS  Google Scholar 

  60. Patten CA, Martin JE, Myers MG, et al.: Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. J Stud Alcohol 1998, 59:327–335.

    PubMed  CAS  Google Scholar 

  61. Anton RF, Moak DH, Waid LR, et al.: Naltrexone and cognitivebehavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial. Am J Psychiatry 1999, 156:1758–1764.

    PubMed  CAS  Google Scholar 

  62. Morgenstern J, Morgan TJ, McCrady BS, et al.: Manual-guided cognitive behavioral therapy training: A promising method for disseminating empirically supported substance abuse treatments to the practice community. Psychol Addict Behav 2001, 15:83–88.

    Article  PubMed  CAS  Google Scholar 

  63. DeRubeis RJ, Crits-Christoph P: Empirically supported individual and group psychological treatments for adult mental disorders. J Consult Clin Psychol 1998, 66:37–52.

    Article  PubMed  CAS  Google Scholar 

  64. Carroll KM, Rounsaville BJ, Nich C, et al.: One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: Delayed emergence of psychotherapy effects. Arch Gen Psychiatry 1994, 51:989–997.

    PubMed  CAS  Google Scholar 

  65. Carroll KM, Nich C, Ball SA, et al.: One year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers: Sustained effects of treatment. Addiction 2000, 95:1335–1349. This study showed delayed emergence effects of cognitive-behavioral approaches.

    Article  PubMed  CAS  Google Scholar 

  66. McKay JR, Alterman AI, Cacciola JS, et al.: Continuing care for cocaine dependence: Comprehensive 2-year outcomes. J Consult Clin Psychol 1999, 63:70–78.

    Google Scholar 

  67. Monti PM, Rohsenow DJ, Michalec E, et al.: Brief coping skills treatment for cocaine abuse: Substance abuse outcomes at three months. Addiction 1997, 92:1717–1728.

    Article  PubMed  CAS  Google Scholar 

  68. Rawson RA, Huber A, McCann MJ, et al.: A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance for cocaine dependence. Arch Gen Psychiatry 2002, 59:817–824.

    Article  PubMed  CAS  Google Scholar 

  69. Bien TH, Miller WR, Tonigan JS: Brief interventions for alcohol problems: A review. Addiction 1993, 88:315–335.

    Article  PubMed  CAS  Google Scholar 

  70. Wilk AI, Jensen NM, Havighurst TC: Meta-analysis of randomized controlled trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern Med 1997, 12:274–283.

    Article  PubMed  CAS  Google Scholar 

  71. Swanson AJ, Pantalon MV, Cohen KR: Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. J Nerv Ment Dis 1999, 187:630–635.

    Article  PubMed  CAS  Google Scholar 

  72. Saunders B, Wilkinson C, Philips M: The impact of a brief motivational intervention with opiate users attending a methadone programme. Addiction 1995, 90:415–424.

    Article  PubMed  CAS  Google Scholar 

  73. Stotts AL, Schmitz JM, Rhoades HM, Grabowski J: Motivational interviewing with cocaine-dependent patients: A pilot study. J Consult Clin Psychol 2001, 69:858–862.

    Article  PubMed  CAS  Google Scholar 

  74. Martino S, Carroll KM, O’Malley SS, Rounsaville BJ: Motivational interviewing with psychiatrically ill substance abusing patients. Am J Addict 2000, 9:88–91.

    Article  PubMed  CAS  Google Scholar 

  75. Carroll KM, Libby B, Sheehan J, Hyland N: Motivational interviewing to enhance treatment initiation in substance abusers: An effectiveness study. Am J Addict 2001, 10:335–339.

    Article  PubMed  CAS  Google Scholar 

  76. Miller WR, Yahne CE, Tonigan JS: Motivational interviewing in drug abuse services: A randomized trial. J Consult Clin Psychol 2003, 71:754–763.

    Article  PubMed  Google Scholar 

  77. Donovan DM, Rosengren DB, Downey L, et al.: Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction 2001, 96:1149–1160.

    Article  PubMed  CAS  Google Scholar 

  78. Booth RE, Kwiatkowski C, Iguchi MY, et al.: Facilitating treatment entry among out-of-treatment injection drug users. Public Health Reports 1998, 113(Suppl 1):116–128.

    PubMed  Google Scholar 

  79. Baker A, Lewin T, Reichler H, et al.: Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatr Scand 2002, 106:233–240.

    Article  PubMed  Google Scholar 

  80. Henggeler SW, Pickrel SG, Brondino MJ, Crouch JL: Eliminating (almost) treatment dropout of substance abusing or dependent delinquents through home-based multisystemic therapy. Am J Psychiatry 1996, 153:427–428.

    PubMed  CAS  Google Scholar 

  81. Liddle HA, Dakof GA, Parker K, et al.: Multidimensional family therapy for adolescent drug abuse: Results of a randomized clinical trial. Am J Drug Alcohol Abuse 2001, 27:651–688.

    Article  PubMed  CAS  Google Scholar 

  82. Stanton MD, Shadish WR: Outcome, attrition, and familycouples treatment for drug abuse: A meta-analysis and review of the controlled, comparative studies. Psychol Bull 1997, 122:170–191.

    Article  PubMed  CAS  Google Scholar 

  83. Liddle HA, Dakof G: Efficacy of family therapy for drug abuse: Promising but not definitive. J Marital Fam Ther 1995, 21:511–543.

    Google Scholar 

  84. Waldron HB: Adolescent substance abuse and family therapy outcome: A review of randomized trials. Adv Clin Child Psychol 1997, 19:199–234.

    Google Scholar 

  85. Deas D, Thomas SE: An overview of controlled studies of adolescent substance abuse treatment. Am J Addict 2001, 10:178–189.

    Article  PubMed  CAS  Google Scholar 

  86. Szapocznik J, Perez-Vidal A, Brickman AL, et al.: Engaging adolescent drug abusers and their families in treatment: A strategic structural systems approach. J Consult Clin Psychol 1988, 56:552–557.

    Article  PubMed  CAS  Google Scholar 

  87. Szapocznik J, Hervis O: Brief Strategic Family Therapy. Rockville, Maryland: NIDA; In press.

  88. Waldron HB, Slesnick N, Brody JL, et al.: Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol 2001, 69:802–813.

    Article  PubMed  CAS  Google Scholar 

  89. Azrin NH, McMahon PT, Donohue B, et al.: Behavior therapy for drug abuse: A controlled treatment outcome study. Behav Res Ther 1994, 32:857–866.

    Article  PubMed  CAS  Google Scholar 

  90. Azrin NH, Acierno R, Kogan ES, et al.: Follow-up results of supportive versus behavioral therapy for illicit drug use. Behav Res Ther 1996, 34:41–46.

    Article  PubMed  CAS  Google Scholar 

  91. Azrin NH, Donohue B, Besalel VA: Youth drug abuse treatment: A controlled outcome study. J Child Adolesc Subst Abuse 1994, 3:1–16.

    Article  Google Scholar 

  92. Azrin NH, Donohue B, Teichner G, et al.: A controlled evaluation and description of individual cognitive problem solving and family-behavioral therapies in conduct disordered and substance dependent youth. J Child Adolesc Subst Abuse 2001, 11:1–43.

    Article  Google Scholar 

  93. Henggeler SW, Melton GB, Smith LA: Family preservation using Multisystemic Therapy: An effecitve alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol 1992, 60:953–961.

    Article  PubMed  CAS  Google Scholar 

  94. Borduin CM, Mann BJ, Cone LT, et al.: Multisystemic treatment of serious juvenile offenders: Long-term prevention of criminality and violence. J Consult Clin Psychol 1995, 63:569–578.

    Article  PubMed  CAS  Google Scholar 

  95. Huey SJ, Henggeler SW, Brondino MJ, Pickrel S: Mechanisms of change in multisystemic therapy: reducing delinquent behavior through therapist adherence and improved family and peer functioning. J Consult Clin Psychol 2000, 68:451–467.

    Article  PubMed  Google Scholar 

  96. Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG: Four-year follow-up of multisystemic therapy with substanceabusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry 2002, 41:868–874.

    Article  PubMed  Google Scholar 

  97. Szapocznik J, Hervis O, Schwartz S: Brief Strategic Family Therapy for Adolescent Drug Abuse. Bethesda, MD: NIDA; 2003.

    Google Scholar 

  98. COMBINE Study Research Group: Testing combined pharmacotherapies and behavioral therapies in alcohol dependence: Rationale and methods. Alcohol Clin Exp Res 2003, 27:1107–1122.

    Article  Google Scholar 

  99. COMBINE Study Research Group: Testing combined pharmacotherapies and behavioral intervention in alcohol dependence: A pilot study. Alcohol Clin Exp Res 2003, 27:1123–1131.

    Article  Google Scholar 

  100. Kosten TR, Oliveto A, Feingold A, et al.: Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend 2003, 70:315–325.

    Article  PubMed  CAS  Google Scholar 

  101. Schottenfeld RS, Chawarski MC, Pakes JA, et al.: Methadone vs buprenorphine with contingency management or voucher control for cocaine and opioid dependence. Am J Psychiatry, 2005, 162:340–349.

    Article  PubMed  Google Scholar 

  102. O’Malley SS, Jaffe AJ, Chang G, et al.: Six month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996, 53:217–224.

    PubMed  CAS  Google Scholar 

  103. Hall SM, Humfleet GL, Reus VI, et al.: Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry 2002, 59:930–936.

    Article  PubMed  CAS  Google Scholar 

  104. Schmitz JM, Stotts AL, Rhoades HM, Grabowski J: Naltrexone and relapse prevention for cocaine-dependent patients. Addict Behav 2001, 26:167–180.

    Article  PubMed  CAS  Google Scholar 

  105. Heinala P, Alho H, Kiianmaa K, et al.: Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: A factorial double blind, placebo controlled trial. J Clin Psychopharmacol 2001, 21:287–292.

    Article  PubMed  CAS  Google Scholar 

  106. O’Malley SS, Rounsaville BJ, Farren C, et al.: Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs. specialty care: A nested sequence of three randomized trials. Arch Intern Med 2003, 163:1695–1704.

    Article  PubMed  CAS  Google Scholar 

  107. Carroll KM, Rounsaville BJ, Kosten TR: Choosing a behavioral therapy platform for pharmacotherapy of substance users. Drug Alcohol Depend 2004, 75:123–134.

    Article  PubMed  Google Scholar 

  108. McLellan AT, Arndt IO, Metzger D, et al.: The effects of psychosocial services in substance abuse treatment. JAMA 1993, 269:1953–1959.

    Article  PubMed  CAS  Google Scholar 

  109. Fuller RK, Branchey L, Brightwell DR, et al.: Disulfiram treatment of alcoholism: A Veterans Administration cooperative study. JAMA 1986, 256:1449–1455.

    Article  PubMed  CAS  Google Scholar 

  110. Volpicelli JR, Rhines KC, Rhines JS, et al.: Naltrexone and alcohol dependence: Role of subject compliance. Arch Gen Psychiatry 1997, 54:737–742.

    PubMed  CAS  Google Scholar 

  111. O’Malley SS, Carroll KM: Psychotherapeutic considerations in pharmacologic trials. Alcohol Clin Exp Res 1996, 20:17A-22A.

    Article  PubMed  CAS  Google Scholar 

  112. Institute of Medicine: Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press; 1998. This milestone report showed the need for evidence-based approaches in substance abuse.

    Google Scholar 

  113. Morgenstern J, Blanchard KA, Morgan TJ, et al.: Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: Within treatment and posttreatment findings. J Consult Clin Psychol 2001, 69:1007–1017.

    Article  PubMed  CAS  Google Scholar 

  114. Miller WR, Mount KA: A small study of training in motivational interviewing: Does one workshop change clinician and client behavior? Behav Cogn Psychother 2001, 29:457–471.

    Article  Google Scholar 

  115. McLellan AT, Carise D, Kleber HD: Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat 2003, 25:117–121. This is an important assessment of the condition of the US substance abuse treatment delivery system.

    Article  PubMed  Google Scholar 

  116. Miller WR, Yahne CE, Moyers TB, et al.: A randomized trial of methods to help clinicians learn motivation interviewing. J Consult Clin Psychol 2004, 72:1050–1062.

    Article  PubMed  Google Scholar 

  117. Sholomskas D, Syracuse G, Ball SA, et al.: We don’t train in vain: A dissemination trial of three strategies for training clinicians in cognitive behavioral therapy. J Consult Clin Psychol 2005, 73:106–115.

    Article  PubMed  Google Scholar 

  118. Carroll KM, Farentinos C, Ball SA, et al.: MET meets the real world: Design issues and clinical strategies in the Clinical Trials Network. J Subst Abuse Treat 2002, 23:73–80.

    Article  PubMed  Google Scholar 

  119. Petry NM, Peirce JM, Stitzer ML, et al.: Prize-based incentives increase retention in outpatient psychosocial treatment programs: Results of the National Institute on Drug Abuse Clinical Trials Network study. Arch Gen Psychiatry, In press.

  120. Peirce JM, Petry NM, Stitzer ML, et al.: Lower-cost incentives increase stimulant abstinence in methadone maintenance community treatment: Results of the NIDA Clinical Trials Network multi-site study. Addiction, In press.

  121. Carroll KM, Ball SA, Nich C, et al.: Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug Alcohol Depend, In press.

  122. Carroll KM: Combined treatments for substance dependence. In Combined Treatments for Mental Disorders: Pharmacological and Psychotherapeutic Strategies for Intervention. Edited by Sammons MT, Schmidt NB. Washington, DC: APA Press; 2001:215–238.

    Chapter  Google Scholar 

  123. Luborsky L, Diguer L, Seligman DA, et al.: The researcher’s own therapy allegiances: A ‘wild card’ in comparison of treatment efficacy. Clin Psychol Sci Pract 1999, 6:95–106.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Substance Abuse, Yale University School of Medicine, 950 Campbell Avenue (151D), 06516, West Haven, CT, USA

    Kathleen M. Carroll PhD

Authors
  1. Kathleen M. Carroll PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carroll, K.M. Recent advances in the psychotherapy of addictive disorders. Curr Psychiatry Rep 7, 329–336 (2005). https://doi.org/10.1007/s11920-005-0032-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-005-0032-5

Keywords

Search

Navigation